Work

A phase II trial of oral etoposide with mitoxantrone and ifosfamide/mesna consolidated with intravenous etoposide, methylprednisolone, high-dose arabinoside, and cisplatin as salvage therapy for relapsing and/or refractory lymphomas

Year: 1994

Type: article

Study design: Clinical Trial

Source: Investigational New Drugs

DOI: 10.1007/bf00873962

Authors: Jorge E. Romaguera, M. Alma Rodriguez, Frederick B. Hagemeister, Peter McLaughlin, Forrest Swan, Dennis F. Moore, Andreas H. Sarris, Anas Younes, Debbie Hill, Fernando Cabanillas

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute

OpenAlex ID: W2039598541

FWCI:

Cites: 9

Cited by: 2

Related to: 10